Central and South Europe, especially the Balkans is a region with its own unique dynamics and challenges. From the complex regulatory environment to rapidly growing economy and developing infrastructure. More than that, the market in Central and South Europe is often characterized by intense competition, both from domestic players and international companies seeking to capitalize on the region’s growth opportunities. Companies entering these markets need to differentiate themselves and tailor their strategies to meet local demands effectively.
In this presentation you will learn:
- International reference pricing – calculation methods and problems in practice that may lead to the withdrawal of some products from the market of reimbursed drugs
- How managed entry agreements and other innovative reimbursement models give pharmaceutical companies more opportunities to get their innovative medicines to patients
- How to work with stakeholders when the regulations are becoming much stricter?
- How to deal with resistance from doctors to follow stricter processes?
&nsbp;
